Spis treści:
Spis załącznikĂłw:
FS_Q1_2018.zip (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załącznikĂłw:
FS_Q1_2018.zip (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 16 | / | 2018 | ||||||||
| Date of issue: | 2018-04-27 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Financial report for the period ending 31.03.2018 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| 1. Financial report according to IFRS as at 31 March 2018 2. Notes to the financial report as at 31 March 2018 3. Management report as at 31 March 2018 4. Insider information as at 31 March 2018 5. Additional information as at 31 March 2018 6. Financial report according to BFCS standards as at 31 March 2018 7. Annex 9 as at 31 March 2018 8. Declaration as at 31 March 2018 |
|||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| FS_Q1_2018.zipFS_Q1_2018.zip | Financial report for the period ending 31.03.2018 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-04-27 | Ognian Donev | Executive director | |||
Źródło:Komunikaty spółek (ESPI)
